Comment diagnostique-t-on la paralysie cérébrale ?
Le diagnostic repose sur l'évaluation clinique, l'historique médical et des examens d'imagerie.
Paralysie cérébraleImagerie par résonance magnétique
#2
Quels tests sont utilisés pour le diagnostic ?
Des tests neurologiques, des évaluations motrices et parfois des IRM sont utilisés.
Évaluation neurologiqueImagerie par résonance magnétique
#3
À quel âge peut-on diagnostiquer la paralysie cérébrale ?
Elle peut être diagnostiquée dès l'âge de 6 mois, mais souvent plus tard dans l'enfance.
Paralysie cérébraleDéveloppement de l'enfant
#4
Quels signes précoces indiquent une paralysie cérébrale ?
Des retards dans le développement moteur, une posture anormale ou des mouvements involontaires.
Retard de développementMouvements anormaux
#5
Le diagnostic est-il toujours précis ?
Le diagnostic peut être complexe et nécessite une observation prolongée des symptômes.
Diagnostic médicalSymptômes
Symptômes
5
#1
Quels sont les symptômes courants de la paralysie cérébrale ?
Les symptômes incluent des troubles du mouvement, des spasmes musculaires et des problèmes d'équilibre.
SymptômesTroubles du mouvement
#2
La paralysie cérébrale affecte-t-elle la parole ?
Oui, elle peut entraîner des difficultés de communication et des troubles de la parole.
Troubles de la paroleParalysie cérébrale
#3
Y a-t-il des variations dans les symptômes ?
Oui, les symptômes varient selon le type de paralysie cérébrale et la gravité.
Variabilité des symptômesTypes de paralysie cérébrale
#4
Les enfants atteints ont-ils des problèmes d'apprentissage ?
Certains peuvent avoir des difficultés d'apprentissage, mais cela dépend de chaque cas.
Difficultés d'apprentissageParalysie cérébrale
#5
Les symptômes peuvent-ils s'aggraver avec le temps ?
Les symptômes peuvent évoluer, mais une intervention précoce peut aider à gérer la progression.
Évolution des symptômesIntervention précoce
Prévention
5
#1
Peut-on prévenir la paralysie cérébrale ?
Certaines causes peuvent être évitées, comme les infections pendant la grossesse.
PréventionInfections pendant la grossesse
#2
Quel rôle joue la santé maternelle ?
Une bonne santé maternelle avant et pendant la grossesse réduit le risque de paralysie cérébrale.
Santé maternelleGrossesse
#3
Les soins prénatals sont-ils importants ?
Oui, des soins prénatals réguliers aident à détecter et à gérer les risques potentiels.
Soins prénatalsRisques de grossesse
#4
Comment éviter les traumatismes à la naissance ?
Des soins obstétriques appropriés peuvent réduire le risque de traumatismes à la naissance.
Traumatismes à la naissanceSoins obstétriques
#5
Les vaccinations peuvent-elles aider ?
Oui, certaines vaccinations préviennent des infections qui pourraient causer des dommages cérébraux.
VaccinationsInfections
Traitements
5
#1
Quels traitements sont disponibles pour la paralysie cérébrale ?
Les traitements incluent la physiothérapie, l'orthophonie et parfois des médicaments.
PhysiothérapieTraitement médical
#2
La chirurgie est-elle une option de traitement ?
Oui, la chirurgie peut être envisagée pour corriger des déformations ou améliorer la fonction.
Chirurgie orthopédiqueParalysie cérébrale
#3
Les médicaments peuvent-ils aider ?
Des médicaments peuvent être prescrits pour réduire les spasmes musculaires et la douleur.
MédicamentsSpasmes musculaires
#4
Comment la physiothérapie aide-t-elle ?
La physiothérapie améliore la mobilité, la force et la coordination des mouvements.
PhysiothérapieRéhabilitation
#5
Les traitements sont-ils personnalisés ?
Oui, les traitements sont adaptés aux besoins spécifiques de chaque patient.
Médecine personnaliséePlan de traitement
Complications
5
#1
Quelles complications peuvent survenir ?
Les complications incluent des problèmes respiratoires, des troubles de l'alimentation et des infections.
Complications médicalesTroubles respiratoires
#2
La paralysie cérébrale augmente-t-elle le risque d'autres maladies ?
Oui, elle peut augmenter le risque de maladies comme l'épilepsie et les troubles mentaux.
ÉpilepsieTroubles mentaux
#3
Les complications affectent-elles la qualité de vie ?
Oui, les complications peuvent significativement affecter la qualité de vie des patients.
Qualité de vieComplications
#4
Comment gérer les complications ?
Une approche multidisciplinaire est essentielle pour gérer les complications efficacement.
Gestion des complicationsApproche multidisciplinaire
#5
Les complications sont-elles évitables ?
Certaines complications peuvent être évitées avec un suivi médical approprié et des soins.
Prévention des complicationsSuivi médical
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent des naissances prématurées, des infections et des anomalies génétiques.
Facteurs de risqueNaissance prématurée
#2
L'âge maternel influence-t-il le risque ?
Oui, les femmes plus âgées ont un risque accru de complications pendant la grossesse.
Âge maternelComplications de grossesse
#3
Les jumeaux ont-ils un risque plus élevé ?
Oui, les naissances multiples augmentent le risque de paralysie cérébrale.
Naissances multiplesParalysie cérébrale
#4
Les infections pendant la grossesse sont-elles un risque ?
Oui, certaines infections comme la rubéole peuvent augmenter le risque de paralysie cérébrale.
Infections pendant la grossesseRubéole
#5
Les antécédents familiaux jouent-ils un rôle ?
Oui, des antécédents familiaux de troubles neurologiques peuvent augmenter le risque.
Antécédents familiauxTroubles neurologiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Paralysie cérébrale : Questions médicales les plus fréquentes",
"headline": "Paralysie cérébrale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Paralysie cérébrale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Paralysie cérébrale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Encéphalopathies",
"url": "https://questionsmedicales.fr/mesh/D001927",
"about": {
"@type": "MedicalCondition",
"name": "Encéphalopathies",
"code": {
"@type": "MedicalCode",
"code": "D001927",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Paralysie cérébrale",
"alternateName": "Cerebral Palsy",
"code": {
"@type": "MedicalCode",
"code": "D002547",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Michael Shevell",
"url": "https://questionsmedicales.fr/author/Michael%20Shevell",
"affiliation": {
"@type": "Organization",
"name": "From the Departments of Pediatrics and Neurology/Neurosurgery, McGill University; and Division of Pediatric Neurology, Montreal Children's Hospital-McGill University Health Centre, Canada. michael.shevell@muhc.mcgill.ca."
}
},
{
"@type": "Person",
"name": "Maryam Oskoui",
"url": "https://questionsmedicales.fr/author/Maryam%20Oskoui",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada."
}
},
{
"@type": "Person",
"name": "Gija Rackauskaite",
"url": "https://questionsmedicales.fr/author/Gija%20Rackauskaite",
"affiliation": {
"@type": "Organization",
"name": "Paediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark."
}
},
{
"@type": "Person",
"name": "Israt Jahan",
"url": "https://questionsmedicales.fr/author/Israt%20Jahan",
"affiliation": {
"@type": "Organization",
"name": "CSF Global, Dhaka, Bangladesh."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Predictors of whole exome sequencing in dystonic cerebral palsy and cerebral palsy-like disorders.",
"datePublished": "2023-03-04",
"url": "https://questionsmedicales.fr/article/36997436",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2023.105352"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cerebral Palsy: Hip Surveillance.",
"datePublished": "2022-09-01",
"url": "https://questionsmedicales.fr/article/36098607",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/19382359-20220706-06"
}
},
{
"@type": "ScholarlyArticle",
"name": "Acceptability of neural stem cell therapy for cerebral palsy: survey of the Australian cerebral palsy community.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36737828",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13287-023-03246-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Public health indicators for cerebral palsy: A European collaborative study of the Surveillance of Cerebral Palsy in Europe network.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36722642",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ppe.12950"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Review of Food Texture Modification among Individuals with Cerebral Palsy: The Challenges among Cerebral Palsy Families.",
"datePublished": "2022-12-09",
"url": "https://questionsmedicales.fr/article/36558401",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu14245241"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphalopathies",
"item": "https://questionsmedicales.fr/mesh/D001927"
},
{
"@type": "ListItem",
"position": 5,
"name": "Paralysie cérébrale",
"item": "https://questionsmedicales.fr/mesh/D002547"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Paralysie cérébrale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Paralysie cérébrale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Paralysie cérébrale",
"description": "Comment diagnostique-t-on la paralysie cérébrale ?\nQuels tests sont utilisés pour le diagnostic ?\nÀ quel âge peut-on diagnostiquer la paralysie cérébrale ?\nQuels signes précoces indiquent une paralysie cérébrale ?\nLe diagnostic est-il toujours précis ?",
"url": "https://questionsmedicales.fr/mesh/D002547#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Paralysie cérébrale",
"description": "Quels sont les symptômes courants de la paralysie cérébrale ?\nLa paralysie cérébrale affecte-t-elle la parole ?\nY a-t-il des variations dans les symptômes ?\nLes enfants atteints ont-ils des problèmes d'apprentissage ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D002547#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Paralysie cérébrale",
"description": "Peut-on prévenir la paralysie cérébrale ?\nQuel rôle joue la santé maternelle ?\nLes soins prénatals sont-ils importants ?\nComment éviter les traumatismes à la naissance ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D002547#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Paralysie cérébrale",
"description": "Quels traitements sont disponibles pour la paralysie cérébrale ?\nLa chirurgie est-elle une option de traitement ?\nLes médicaments peuvent-ils aider ?\nComment la physiothérapie aide-t-elle ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D002547#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Paralysie cérébrale",
"description": "Quelles complications peuvent survenir ?\nLa paralysie cérébrale augmente-t-elle le risque d'autres maladies ?\nLes complications affectent-elles la qualité de vie ?\nComment gérer les complications ?\nLes complications sont-elles évitables ?",
"url": "https://questionsmedicales.fr/mesh/D002547#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Paralysie cérébrale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge maternel influence-t-il le risque ?\nLes jumeaux ont-ils un risque plus élevé ?\nLes infections pendant la grossesse sont-elles un risque ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D002547#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la paralysie cérébrale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique, l'historique médical et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests neurologiques, des évaluations motrices et parfois des IRM sont utilisés."
}
},
{
"@type": "Question",
"name": "À quel âge peut-on diagnostiquer la paralysie cérébrale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être diagnostiquée dès l'âge de 6 mois, mais souvent plus tard dans l'enfance."
}
},
{
"@type": "Question",
"name": "Quels signes précoces indiquent une paralysie cérébrale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des retards dans le développement moteur, une posture anormale ou des mouvements involontaires."
}
},
{
"@type": "Question",
"name": "Le diagnostic est-il toujours précis ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic peut être complexe et nécessite une observation prolongée des symptômes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la paralysie cérébrale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles du mouvement, des spasmes musculaires et des problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "La paralysie cérébrale affecte-t-elle la parole ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des difficultés de communication et des troubles de la parole."
}
},
{
"@type": "Question",
"name": "Y a-t-il des variations dans les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes varient selon le type de paralysie cérébrale et la gravité."
}
},
{
"@type": "Question",
"name": "Les enfants atteints ont-ils des problèmes d'apprentissage ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains peuvent avoir des difficultés d'apprentissage, mais cela dépend de chaque cas."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent évoluer, mais une intervention précoce peut aider à gérer la progression."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la paralysie cérébrale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines causes peuvent être évitées, comme les infections pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la santé maternelle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne santé maternelle avant et pendant la grossesse réduit le risque de paralysie cérébrale."
}
},
{
"@type": "Question",
"name": "Les soins prénatals sont-ils importants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins prénatals réguliers aident à détecter et à gérer les risques potentiels."
}
},
{
"@type": "Question",
"name": "Comment éviter les traumatismes à la naissance ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins obstétriques appropriés peuvent réduire le risque de traumatismes à la naissance."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations préviennent des infections qui pourraient causer des dommages cérébraux."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la paralysie cérébrale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la physiothérapie, l'orthophonie et parfois des médicaments."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée pour corriger des déformations ou améliorer la fonction."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour réduire les spasmes musculaires et la douleur."
}
},
{
"@type": "Question",
"name": "Comment la physiothérapie aide-t-elle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La physiothérapie améliore la mobilité, la force et la coordination des mouvements."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont adaptés aux besoins spécifiques de chaque patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes respiratoires, des troubles de l'alimentation et des infections."
}
},
{
"@type": "Question",
"name": "La paralysie cérébrale augmente-t-elle le risque d'autres maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut augmenter le risque de maladies comme l'épilepsie et les troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire est essentielle pour gérer les complications efficacement."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles évitables ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées avec un suivi médical approprié et des soins."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des naissances prématurées, des infections et des anomalies génétiques."
}
},
{
"@type": "Question",
"name": "L'âge maternel influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes plus âgées ont un risque accru de complications pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Les jumeaux ont-ils un risque plus élevé ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les naissances multiples augmentent le risque de paralysie cérébrale."
}
},
{
"@type": "Question",
"name": "Les infections pendant la grossesse sont-elles un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections comme la rubéole peuvent augmenter le risque de paralysie cérébrale."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles neurologiques peuvent augmenter le risque."
}
}
]
}
]
}
From the Departments of Pediatrics and Neurology/Neurosurgery, McGill University; and Division of Pediatric Neurology, Montreal Children's Hospital-McGill University Health Centre, Canada. michael.shevell@muhc.mcgill.ca.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Division of Occupational Therapy and Physical Therapy, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 4007, Cincinnati, OH 45229, USA.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Division of Pediatric Neurology, Department of Neurology, School of Medicine, Washington University in St Louis and St Louis Children's Hospital, St Louis, Missouri; aravamuthanb@wustl.edu.
Division of Pediatric Neurology, Department of Neurology, School of Medicine, Washington University in St Louis and St Louis Children's Hospital, St Louis, Missouri.
Cerebral palsy (CP) is a group of permanent disorders attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. Cerebral palsy-like (CP-like) disorders may clin...
Individuals with early onset neurodevelopmental disorder (ND) manifesting with dystonia as a core feature were divided into CP or CP-like cohorts based on their clinical picture and disease course. De...
A total of 122 patients were included and divided into the CP group with 70 subjects (30 males; mean age 18y5m±16y6m, mean GMFCS score 3.3 ± 1.4), and the CP-like group with 52 subjects (29 males; mea...
WES is a useful diagnostic method for patients with dystonic ND, regardless of their presentation as a CP or CP-like phenotype....
Patients with cerebral palsy are known to be at risk for hip displacement and dislocation. Progressive hip displacement is known to cause a variety of problems including pain, impaired sitting balance...
Neural stem cells (NSCs) have the potential to engraft and replace damaged brain tissue, repairing the damaged neonatal brain that causes cerebral palsy (CP). There are procedures that could increase ...
Australian residents with CP and parents/carers of those with CP completed a questionnaire to determine their willingness to use NSCs from three sources (fetal, embryonic and induced pluripotent stem ...
In total, 232 responses were analyzed. Participants were willing to use NSCs from all three cell sources and were willing to undergo NSC therapy despite the need for neurosurgery and immunosuppression...
Hypothetical NSC therapy was acceptable to the Australian CP community. This study has identified important findings from the CP community which can be used to inform future NSC research, including th...
Public health indicators (PHIs) play an increasingly important role in health policy decision-making. Although cerebral palsy (CP) is the commonest physical disability in children, its impact at popul...
We aimed to propose six PHIs for CP designed to annually document the extent of CP and effectiveness of perinatal organisation, the burden of this condition, access to health services and preventive h...
The study included children with CP born between 2002 and 2011. Harmonised data (number of cases, functional profile, imaging) were extracted from the Surveillance of Cerebral Palsy in Europe (SCPE) d...
Analyses were performed on a total of 8621 children with CP from 12 to 17 SCPE registries. A decreasing prevalence of pre/perinatal CP overall, as well as in preterm and full-term-born children, was o...
Population-based CP registries can provide data that are relevant for generating key outcomes of interest at the population level, thus potentially contributing to improving public health policies for...
Individuals with cerebral palsy (CP) frequently present with multiple feeding problems, which may require food texture modification to ensure safe feeding. This review aims to explore the challenges i...
Cerebral palsy (CP) is the most prevalent neuromotor disability in childhood, but for most cases the etiology remains unexplained. Seasonal variation in the conception of CP may provide clues for thei...
To evaluate whether the month or season of conception is associated with CP occurrence....
This statewide cohort study examined more than 4 million live births that were registered in the California birth records during 2007 to 2015 and were linked to CP diagnostic records (up to year 2021)...
The month and season of conception were estimated based on the child's date of birth and the length of gestation recorded in the California birth records....
CP status was ascertained from the diagnostic records obtained from the Department of Developmental Services in California. Poisson regression was used to estimate the relative risk (RR) and 95% CI fo...
Records of 4 468 109 children (51.2% male; maternal age: 28.3% aged 19 to 25 years, 27.5% aged 26 to 30 years; maternal race and ethnicity: 5.6% African American or Black, 13.5% Asian, 49.8% Hispanic ...
In this cohort study in California, children conceived in winter and spring had a small increase in CP risk. These findings suggest that seasonally varying environmental factors should be considered i...
This narrative review summarizes the latest advances in cerebral palsy and identifies where more research is required. Several studies on cerebral palsy were analyzed to generate a general idea of the...
To review the neurosurgical treatments of children with movement disorders associated with cerebral palsy (CP) during the previous decades, up to the present day....
An extensive literature review was undertaken to identify important publications about this subject. My experience treating children with these disorders over the past three decades was included in th...
Peripheral neurotomies have been developed for children with focal spasticity. For those with spastic paraparesis, selective lumbar rhizotomies were developed, and for those with spastic quadriparesis...
Treatment of children with movement disorders associated with CP increased slowly in the 1970s and 1980s but accelerated rapidly in the 1990s with the introduction of lumbar dorsal rhizotomies and int...
To identify the earliest predictors of risk for diagnosis of cerebral palsy (CP)....
A comprehensive literature search was conducted using various databases. The publications were reviewed to identify risk factors for CP from conception to early infancy. Studies were critically apprai...
The initial search yielded 129 studies and 20 studies were included. Forty-seven risk factors for CP were extracted of which several were duplicate terms. The significant risk factors found to be indi...
Twenty-three factors were consistently reported as predictors of CP....
Early identification of cerebral palsy (CP) facilitates optimal care, support, and outcomes for children and their families. Ideally, infants with risk factors or developmental deviations should be ev...
